BIOTON S.A. logo

BIOTON S.A.

Biotechnologia w trosce o pacjenta

257 employees · est. 1989 · Poland

VS
DreaMed Diabetes logo

DreaMed Diabetes

Empowering healthcare professionals with AI-driven diabetes care that ensures optimal treatment plans and improved patient outcomes worldwide.

est. 2014

BIOTON S.A. is the older company (1989 vs 2014).

Side-by-Side Comparison

BIOTON S.A. DreaMed Diabetes
Founded
1989 older 2014
Headquarters
Poland Not tracked yet
Employees
257 Not tracked yet
Industry
Biopharma, Biotechnology, Finance AI, Biotechnology, Enterprise Software
Funding Stage
Private Equity Grant
Total Funding
Not tracked yet $10.30M
Funding Rounds
1 3
Services
insulin synthesis and production, biopharmaceutical research and development, patient education and specialist consultations, manufacturing of medical devices and pharmaceuticals, environmental protection in drug production Not tracked yet
Target Customers
diabetes patients, healthcare professionals, pharmaceutical investors, medical device users, research institutions Not tracked yet
Taxonomy
Diabetes Treatment, Human Insulin Production, Recombinant Insulin, Pharmaceuticals, Contract Manufacturing Organization (CMO), Contract Development And Manufacturing Organization (CDMO), Quality Control (QC), Drug Development, Foods For Special Medical Purposes (FSMP), Therapeutics, Over-the-Counter (OTC) Products, Supply Chain, Research & Development, Innovation Artificial Intelligence, Medical Devices, Diabetes Treatment, Decision Support System, FDA Clearance, Insulin Titration, Patient-centered Care, Healthcare Professionals, Clinical Data Analysis, Remote Patient Monitoring
Website
bioton.com dreamed-diabetes.com
BIOTON S.A. logo

About BIOTON S.A.

BIOTON S.A., operating under the slogan "Biotechnologia w trosce o pacjenta", is a leading European biotech company based in Poland and established in 1989. The company specializes in the production of human insulin, both as active pharmaceutical ingredients and in finished forms like cartridges and...

DreaMed Diabetes logo

About DreaMed Diabetes

DreaMed Diabetes is a medical device and SaaS company that specializes in personalized diabetes treatment optimization solutions. Founded in 2014, the company initially gained recognition for commercializing the first artificial pancreas technology, featured in the NEJM. DreaMed Diabetes has since c...

We will tell you when either one moves

BounceWatch watches BIOTON S.A. and DreaMed Diabetes for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at BIOTON S.A. and DreaMed Diabetes — by email.

Frequently Asked Questions

BIOTON S.A. — Biotechnologia w trosce o pacjenta . DreaMed Diabetes — Empowering healthcare professionals with AI-driven diabetes care that ensures optimal treatment plans and improved patient outcomes worldwide.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
BIOTON S.A. has raised undisclosed funding while DreaMed Diabetes has raised $10.30M.
BIOTON S.A. and DreaMed Diabetes operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare BIOTON S.A. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at BIOTON S.A. on 25 Mar 2026, and DreaMed Diabetes on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy